We are live on ! Find out more
PM

Parametrica Management Portfolio holdings

AUM $88M
1-Year Est. Return 48.84%
This Fund
S&P 500
This Quarter Est. Return
+0.49%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$48.9M
AUM Growth
-$42.9M
Cap. Flow
-$39.6M
Cap. Flow %
-81.01%
Top 10 Hldgs %
55.14%
Holding
193
New
27
Increased
13
Reduced
23
Closed
127

Top Buys

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$3.66M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.64M
3
WOLF icon
Wolfspeed
WOLF
+$1.19M
4
MSFT icon
Microsoft
MSFT
+$939K
5
TXG icon
10x Genomics
TXG
+$807K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.3M
2
LI icon
Li Auto
LI
+$2.35M
3
JD icon
JD.com
JD
+$1.63M
4
HTZ icon
Hertz
HTZ
+$1.59M
5
TWTR
Twitter, Inc.
TWTR
+$1.48M

Sector Composition

Rank Sector Weight
1 Technology 24.42%
2 Healthcare 20.81%
3 Communication Services 13.78%
4 Industrials 9.47%
5 Consumer Discretionary 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
26
NVIDIA
NVDA
$4.6T
$635K 1.3%
52,290
+14,420
+38% +$228K
PFE icon
27
Pfizer
PFE
$143B
$623K 1.27%
14,214
-88,592
-86% -$4.3M
QCOM icon
28
Qualcomm
QCOM
$164B
$614K 1.25%
5,433
-1,244
-19% -$171K
DAL icon
29
Delta Air Lines
DAL
$56.7B
$564K 1.15%
20,064
-29,804
-60% -$947K
FOLD
30
DELISTED
Amicus Therapeutics
FOLD
$543K 1.11%
51,999
-82,365
-61% -$918K
DIS icon
31
Walt Disney
DIS
$171B
$521K 1.06%
+5,518
New +$591K
NXST icon
32
Nexstar Media Group
NXST
$6.01B
$457K 0.93%
2,742
-1,183
-30% -$219K
TIL icon
33
Instil Bio
TIL
$49M
$428K 0.87%
4,413
+37
+0.8% +$4.23K
IQV icon
34
IQVIA
IQV
$40.7B
$413K 0.84%
+2,276
New +$499K
DAVA icon
35
Endava
DAVA
$165M
$403K 0.82%
4,998
– –
MU icon
36
Micron Technology
MU
$835B
$391K 0.8%
7,807
-22,765
-74% -$1.32M
FATE icon
37
Fate Therapeutics
FATE
$275M
$318K 0.65%
14,165
-724
-5% -$20.9K
AVNT icon
38
Avient
AVNT
$3.29B
$304K 0.62%
+10,018
New +$415K
GPC icon
39
Genuine Parts
GPC
$17.9B
$291K 0.59%
1,948
+420
+27% +$63.4K
IPSC icon
40
Century Therapeutics
IPSC
$364M
$275K 0.56%
27,840
-1,015
-4% -$10.7K
Y
41
DELISTED
Alleghany Corp
Y
$271K 0.55%
323
-222
-41% -$186K
ONEM
42
DELISTED
1Life Healthcare
ONEM
$259K 0.53%
15,098
+1,644
+12% +$25.8K
SYY icon
43
Sysco
SYY
$40.8B
$255K 0.52%
+3,607
New +$300K
BALL icon
44
Ball Corp
BALL
$17.5B
$250K 0.51%
5,171
+363
+8% +$22.3K
ORCL icon
45
Oracle
ORCL
$339B
$248K 0.51%
+4,056
New +$297K
VFC icon
46
VF Corp
VFC
$5.92B
$234K 0.48%
+7,821
New +$337K
AYX
47
DELISTED
Alteryx Inc
AYX
$225K 0.46%
+4,029
New +$236K
CDW icon
48
CDW
CDW
$18.9B
$224K 0.46%
+1,435
New +$246K
MSI icon
49
Motorola Solutions
MSI
$72.1B
$206K 0.42%
+919
New +$217K
TSVT
50
DELISTED
2seventy bio
TSVT
$161K 0.33%
11,066
-3,700
-25% -$54.9K
1
2
3 4 5

Similar funds

BCP
Balance Capital Partners New York $87.9M AUM
PBCM
Point Break Capital Management Miami, Florida $88M AUM
CVM
Civilization Ventures Management Belvedere Tiburon, California $87.9M AUM
XXIP
Xiamen Xinweidachuang Investment Partnership Xiamen, China $87.8M AUM 29.25% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
RFL
RD Finance Ltd Limassol, Cyprus $88.1M AUM 11.44% 1-Year Est. Return
IAP
Indie Asset Partners Carmel, Indiana $87.8M AUM 27.76% 1-Year Est. Return
MPEM
Marathon Partners Equity Management New York $88.3M AUM 20.65% 1-Year Est. Return

Parametrica Management's Q3 2022 Portfolio in Review

As of Q3 2022, Parametrica Management held 193 positions worth $48.9M, down 47% from $91.9M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Parametrica Management withdrew a net $39.6M in Q3 2022, closing 127 positions and reducing 23 holdings. Its most notable exit was Li Auto, an estimated $2.35M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Parametrica Management opened a new position in iShares Biotechnology ETF worth $3.46M.

  • Parametrica Management's largest Q3 2022 buy was iShares Biotechnology ETF: 29,500 shares worth $3.46M.
  • Parametrica Management added most to Wolfspeed in Q3 2022, an estimated $1.19M increase.
  • Parametrica Management's biggest Q3 2022 reduction was Pfizer, cutting an estimated $4.3M.
  • Parametrica Management fully exited Li Auto in Q3 2022, selling an estimated $2.35M.
  • Parametrica Management's ten largest holdings make up 55% of its $48.9M portfolio in Q3 2022.
  • Parametrica Management opened 27 new positions and closed 127 in Q3 2022.
  • Parametrica Management's portfolio value fell 47% quarter-over-quarter to $48.9M.

Based on Parametrica Management's 13F filing for Q3 2022, filed 3 Nov 2022.